Health ❯Healthcare ❯Pharmaceuticals

Cancer Treatment

Breast Cancer Immunotherapy Lung Cancer Small Cell Lung Cancer Oncology Opdivo Amtagvi Bladder Cancer Clinical Trials Colorectal Cancer Targeted Therapy Prostate Cancer Oncology Research Basal Cell Carcinoma Menin Inhibitors Gastrointestinal Cancer mRNA Technology mRNA Therapies mRNA Therapy Multiple Myeloma Radiation Therapy Springworks Therapeutics Non-Small Cell Lung Cancer Gene Therapy Drug Development Medication Supply Existing Drugs Ogsiveo 3SBio Licensing Deal Drug Pricing

Rajya Sabha Panel Seeks Wider Cancer Drug Price Caps and Standardised Diagnostic Coverage

The proposals are advisory and require policy decisions to take effect.

FDA Grants Accelerated Approval to Zongertinib for HER2-Mutant Lung Cancer

Pfizer Beats Q2 Estimates and Raises 2025 Profit Forecast

BioNTech Halves Q2 Loss as mRNA Cancer Pipeline Advances

Cancer Drugs Reverse Alzheimer’s Pathology in Mice, Advance to Clinical Trials

Glenmark Stock Hits Record High on $700 Million AbbVie Cancer Drug Deal

Merck in Advanced Talks to Acquire Springworks Therapeutics for $3.5 Billion

Bristol Myers Squibb Raises 2025 Forecast After Surpassing Q1 Expectations

UK Grants First Global Approval for GSK’s Blenrep in Two Combination Therapies

Biontech Reports €700 Million Loss and Plans Workforce Restructuring

SpringWorks Shares Surge on Reported Acquisition Talks with Merck KGaA

GSK Acquires US Biotech IDRx in $1.15 Billion Deal to Advance Rare Cancer Treatment

BioNTech Acquires China's Biotheus for $800 Million to Enhance Cancer Drug Development

Biontech's Revenue Surges with Updated Covid-19 Vaccine

FDA Expands Approval of Kisqali for Early-Stage Breast Cancer

Summit Therapeutics' Lung Cancer Drug Outperforms Merck's Keytruda in Trial

Bristol Myers Squibb Surges on Strong Q2 Performance and Raised Guidance